Proteomics Analysis of Trastuzumab Toxicity in the H9c2 Cardiomyoblast Cell Line and its Inhibition by Carvedilol

被引：1

作者：

Beiranvand, Elham ^{[1
]}

Torkashvand, Fatemeh ^{[1
]}

Ostad, Seyed N. ^{[2
]}

Mirzaie, Mehdi ^{[3
,4
]}

Ardakani, Esmat M. ^{[1
]}

Zandi, Fatemeh ^{[1
]}

Sardari, Soroush ^{[1
]}

Salekdeh, Ghasem H. ^{[5
]}

Shokrgozar, Mohammad A. ^{[6
]}

Vaziri, Behrouz ^{[1
]}

机构：

[1] Pasteur Inst Iran, Biotechnol Res Ctr, Prot Chem & Prote Lab, Tehran, Iran

[2] Univ Tehran Med Sci, Fac Pharm, Dept Pharmacol & Toxicol, Tehran, Iran

[3] Macquarie Univ, Dept Mol Sci, Sydney, NSW, Australia

[4] Macquarie Univ, Australian Proteome Anal Facil, Sydney, NSW, Australia

[5] ACECR, Cell Sci Res Ctr, Dept Mol Syst Biol, Royan Inst Stem Cell Biol & Technol, Tehran, Iran

[6] Pasteur Inst Iran, Natl Cell Bank Iran, Tehran, Iran

来源：

CURRENT PHARMACEUTICAL BIOTECHNOLOGY | 2020年 / 21卷 / 13期

关键词：

Cardiotoxicity; trastuzumab; proteomics; carvedilol; cardiomyoblast; translation; CARDIAC DYSFUNCTION; HEART-FAILURE; BETA-BLOCKERS; APOPTOSIS; CARDIOTOXICITY; CARDIOMYOPATHY; MITOCHONDRIAL; CHEMOTHERAPY; MODULATION; RELEASE;

D O I：

10.2174/1389201021666200515135548

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Objective: Heart dysfunctions are the major complications of trastuzumab in patients with Human Epidermal growth factor Receptor-2 (HER2)-positive breast cancers. Methods: In this study, the cytotoxicity of trastuzumab on H9c2 cardiomyoblasts was demonstrated, and the proteome changes of cells were investigated by a tandem mass tagging quantitative approach. The Differentially Abundant Proteins (DAPs) were identified and functionally enriched. Results: We determined that carvedilol, a non-selective beta-blocker, could effectively inhibit trastuzumab toxicity when administrated in a proper dose and at the same time. The proteomics analysis of carvedilol co-treated cardiomyoblasts showed complete or partial reversion in expressional levels of trastuzumab-induced DAPs. Conclusion: Downregulation of proteins involved in the translation biological process is one of the most important changes induced by trastuzumab and reversed by carvedilol. These findings provide novel insights to develop new strategies for the cardiotoxicity of trastuzumab.

引用

页码：1377 / 1385

页数：9

共 38 条

[1] CT- proAVP ( copeptin), MR- proANP and Peroxiredoxin 4 after cardiac arrest: release profiles and correlation to outcome [J].

Annborn, M. ;

Dankiewicz, J. ;

Nielsen, N. ;

Rundgren, M. ;

Smith, J. G. ;

Hertel, S. ;

Struck, J. ;

Friberg, H. .

ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2014, 58 (04) :428-436

[2] In vitro cardiotoxicity evaluation of graphene oxide [J].

Arbo, Marcelo Dutra ;

Altknecht, Louise F. ;

Cattani, Shanda ;

Braga, Wesley, V ;

Peruzzi, Caroline P. ;

Cestonaro, Larissa, V ;

Goethel, Gabriela ;

Duran, Nelson ;

Garcia, Solange Cristina .

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2019, 841 :8-13

[3] Functional Impairment of Human Resident Cardiac Stem Cells by the Cardiotoxic Antineoplastic Agent Trastuzumab [J].

Barth, Andreas S. ;

Zhang, Yiqiang ;

Li, Taosheng ;

Smith, Rachel R. ;

Chimenti, Isotta ;

Terrovitis, Ioannis ;

Davis, Darryl R. ;

Kizana, Eddy ;

Ho, Alice S. ;

O'Rourke, Brian ;

Wolff, Antonio C. ;

Gerstenblith, Gary ;

Marban, Eduardo .

STEM CELLS TRANSLATIONAL MEDICINE, 2012, 1 (04) :289-297

[4] Amyloid β Induces Early Changes in the Ribosomal Machinery, Cytoskeletal Organization and Oxidative Phosphorylation in Retinal Photoreceptor Cells [J].

Deng, Liting ;

Pushpitha, Kanishka ;

Joseph, Chitra ;

Gupta, Veer ;

Rajput, Rashi ;

Chitranshi, Nitin ;

Dheer, Yogita ;

Amirkhani, Ardeshir ;

Kamath, Karthik ;

Pascovici, Dana ;

Wu, Jemma X. ;

Salekdeh, Ghasem Hosseini ;

Haynes, Paul A. ;

Graham, Stuart L. ;

Gupta, Vivek K. ;

Mirzaei, Mehdi .

FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12

[5]

DENG LT, 2019, FRONT MOL NEUROSCI, V12, DOI DOI 10.3389/FNMO1.2019.00024

[6] Examining the Protective Role of ErbB2 Modulation in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes [J].

Eldridge, Sandy ;

Guo, Liang ;

Mussio, Jodie ;

Furniss, Mike ;

Hamre, John, III ;

Davis, Myrtle .

TOXICOLOGICAL SCIENCES, 2014, 141 (02) :547-559

[7] Assessing the translatability of In vivo cardiotoxicity mechanisms to In vitro models using causal reasoning [J].

Enayetallah, Ahmed E. ;

Puppala, Dinesh ;

Ziemek, Daniel ;

Fischer, James E. ;

Kantesaria, Sheila ;

Pletcher, Mathew T. .

BMC PHARMACOLOGY & TOXICOLOGY, 2013, 14

[8] Carvedilol Suppresses Apoptosis and Ion Channel Remodelling of HL-1 Cardiac Myocytes Expressing E334K cMyBPC [J].

Endo, R. ;

Bahrudin, U. ;

Notsu, T. ;

Tanno, S. ;

Onohara, T. ;

Yamaguchi, S. ;

Ikeda, N. ;

Surastri, B. ;

Nakayama, Y. ;

Ninomiya, H. ;

Shirayoshi, Y. ;

Inagaki, Y. ;

Yamamoto, K. ;

Yoshida, A. ;

Hisatome, I. .

DRUG RESEARCH, 2016, 66 (03) :126-129

[9] Modulation of Fatty Acids Oxidation in Heart Failure by Selective Pharmacological Inhibition of 3-Ketoacyl Coenzyme-A Thiolase [J].

Fragasso, Gabriele ;

Spoladore, Roberto ;

Cuko, Amarild ;

Palloshi, Altin .

CURRENT CLINICAL PHARMACOLOGY, 2007, 2 (03) :190-196

[10] Working hard at the nexus between cell signaling and the ribosomal machinery: An insight into the roles of RACK1 in translational regulation [J].

Gallo, Simone ;

Manfrini, Nicola .

TRANSLATION, 2015, 3 (02)

← 1 2 3 4 →